Knowledge Hub

Share this page

Tumours

Ependymoma

An in-depth, evidence-based guide to spinal ependymomas — tumours arising from the lining cells of the spinal cord and its central canal — and how they are recognised, imaged and referred for specialist care.

A spinal ependymoma is a tumour that arises from ependymal cells, the cells that line the fluid spaces of the central nervous system — in the spine, the central canal that runs through the cord, and the filum terminale at the very bottom of the spinal canal. Ependymomas are the commonest tumour to arise within the substance of the adult spinal cord, and a particular subtype, the myxopapillary ependymoma, characteristically occurs at the lower end of the canal around the cauda equina. Most are relatively slow-growing. I want to be open about my role from the outset: I do not personally operate on primary spinal cord tumours such as this. My job is to recognise the problem, arrange the right imaging, and refer you promptly to a trusted colleague who specialises in this surgery and does it in high volume. This page explains what a spinal ependymoma is and how it is assessed.

For information only — not medical advice. The content on this page is patient education to help you understand a condition or treatment. It is not a substitute for personalised assessment by a qualified clinician. Always consult your doctor or specialist about your own symptoms, diagnosis, and treatment decisions.

My role — recognising and referring, not operating

I believe honesty about this matters. Surgery for tumours within the spinal cord, or wrapped among the delicate nerves of the cauda equina, is a highly specialised field, and it is not something I take on. In my view it should be done by surgeons who perform a high volume of this work, because their experience directly affects how completely and how safely the tumour can be removed. So when an ependymoma is found, my role is to identify it, ensure the correct imaging is obtained, and refer you without delay to an expert. What follows is written to help you understand the condition.

What a spinal ependymoma is and how it causes symptoms

Because ependymomas grow within or among the neural tissue and enlarge slowly, symptoms usually develop gradually over months. Common features include pain — often a deep, aching back pain, sometimes worse at night — together with numbness or altered sensation, weakness, clumsiness, and problems with balance and walking; myxopapillary tumours around the cauda equina often cause low back and leg pain and, as they progress, can affect bladder and bowel function. The exact pattern depends on the level of the tumour. Because symptoms build up gradually and can be subtle at first, the diagnosis is sometimes delayed, which is one reason prompt assessment and imaging are important.

How it is diagnosed

The key investigation is an MRI scan with contrast, which shows the tumour, its extent within the cord or around the nerves, and features that suggest it is an ependymoma. Modern classification of these tumours also takes account of their molecular features. This imaging is essential both for diagnosis and for the specialist surgeon to plan treatment. My part is to make sure the imaging is arranged and interpreted correctly so you reach the right specialist promptly.

How it is treated — by a specialist colleague

The mainstay of treatment for a spinal ependymoma is careful microsurgical removal by a specialist, using an operating microscope and continuous nerve-function monitoring to protect the cord and nerves. Many ependymomas — particularly those within the cord — have a plane that allows an experienced surgeon to remove them completely, and the evidence consistently shows that the completeness of removal is one of the most important factors in the long-term outcome. Myxopapillary ependymomas around the cauda equina are ideally removed in one piece where possible, and radiotherapy sometimes has a role, particularly if complete removal is not achievable or the tumour recurs. These are decisions for the specialist team. Because the results depend so heavily on experience, this surgery belongs in high-volume specialist hands, which is why I refer these cases on.

The information provided on this page is intended for educational purposes only and should not be considered personalised medical advice. Every patient is different, and treatment options, risks, expected recovery and outcomes depend upon an individual's diagnosis, general health and personal circumstances. Decisions regarding treatment should always be made following consultation with your treating spinal surgeon or healthcare professional.

Evidence & further reading

  • —Louis DN, et al. The 2021 WHO classification of tumours of the central nervous system: a summary. Neuro Oncol 2021. (PMID 34185076)
  • —Villanueva-Castro E, et al. Spinal ependymomas: updated WHO classification and narrative review. Cureus 2023. (PMID 38125233)
  • —Halvorsen CM, et al. Long-term outcome after resection of intraspinal ependymomas: 86 consecutive cases. Neurosurgery 2010. (PMID 21107192)
  • —Kaner T, et al. 21 cases of spinal cord ependymoma: results of gross-total resection. J Korean Neurosurg Soc 2010. (PMID 20224707)
  • —Gembruch O, et al. Surgical outcome and prognostic factors in spinal cord ependymoma. Ther Adv Neurol Disord 2021. (PMID 34790260)
  • —Wild F, et al. Surgical treatment of spinal ependymomas: experience in 49 patients. World Neurosurg 2018. (PMID 29309981)
  • —Safaee M, et al. Surgical outcomes in spinal cord ependymomas and importance of extent of resection. J Neurosurg Pediatr 2014. (PMID 24506340)
  • —Kotecha R, et al. Role of adjuvant/salvage radiotherapy for spinal myxopapillary ependymomas. J Neurosurg Spine 2020. (PMID 32357340)
  • —Tsai CJ, et al. Outcomes after surgery and radiotherapy for spinal myxopapillary ependymoma. Neurosurgery 2014. (PMID 24818785)
  • —Zhang YW, et al. Clinical management and prognosis of spinal myxopapillary ependymoma: 72 patients. Eur Spine J 2023. (PMID 37027035)
  • —Marchesini N, et al. Cauda equina ependymomas: surgical treatment and long-term outcomes in 125 patients. J Neurosurg Spine 2022. (PMID 34653993)
  • —Klekamp J. Spinal ependymomas. Part 2: ependymomas of the filum terminale. Neurosurg Focus 2015. (PMID 26235024)

Frequently Asked Questions

Found this helpful? Share it

Discuss this with Mr Madi

Personalised, consultant-led advice

Every patient is different. The information on this page is a starting point — Mr Madi will tailor any plan to your specific imaging, symptoms and goals.

Call WhatsApp Email